Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merit Medical Systems (MMSI) Common Equity (2016 - 2025)

Historic Common Equity for Merit Medical Systems (MMSI) over the last 16 years, with Q3 2025 value amounting to $1.5 billion.

  • Merit Medical Systems' Common Equity rose 1556.6% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1556.6%. This contributed to the annual value of $1.4 billion for FY2024, which is 1475.53% up from last year.
  • Per Merit Medical Systems' latest filing, its Common Equity stood at $1.5 billion for Q3 2025, which was up 1556.6% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, Merit Medical Systems' Common Equity peaked at $1.5 billion during Q3 2025, and registered a low of $976.7 million during Q1 2021.
  • Over the past 5 years, Merit Medical Systems' median Common Equity value was $1.2 billion (recorded in 2023), while the average stood at $1.2 billion.
  • In the last 5 years, Merit Medical Systems' Common Equity soared by 392.57% in 2021 and then soared by 1603.21% in 2025.
  • Quarter analysis of 5 years shows Merit Medical Systems' Common Equity stood at $1.0 billion in 2021, then rose by 10.06% to $1.1 billion in 2022, then rose by 5.03% to $1.2 billion in 2023, then rose by 14.76% to $1.4 billion in 2024, then grew by 10.88% to $1.5 billion in 2025.
  • Its Common Equity was $1.5 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.4 billion in Q1 2025.